Stock Scorecard
Stock Summary for Evolus Inc (EOLS) - $7.42 as of 11/12/2026 6:58:51 PM EST
Total Score
5 out of 30
Safety Score
15 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for EOLS
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for EOLS
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for EOLS
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for EOLS
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for EOLS (15 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 0 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for EOLS
Financial Details for EOLS
Company Overview |
|
|---|---|
| Ticker | EOLS |
| Company Name | Evolus Inc |
| Country | N/A |
| Description | Evolus, Inc., a high-performance beauty company, provides aesthetic medical products for physicians and their patients in the United States. The company is headquartered in Newport Beach, California. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 9/30/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 7.42 |
| Price 4 Years Ago | 7.51 |
| Last Day Price Updated | 11/12/2026 6:58:51 PM EST |
| Last Day Volume | 1,287,323 |
| Average Daily Volume | 1,032,847 |
| 52-Week High | 9.31 |
| 52-Week Low | 3.86 |
| Last Price to 52 Week Low | 92.23% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 76.81 |
| Sector PE | 51.83 |
| 5-Year Average PE | -18.66 |
| Free Cash Flow Ratio | 11.78 |
| Industry Free Cash Flow Ratio | 20.38 |
| Sector Free Cash Flow Ratio | 32.69 |
| Current Ratio Most Recent Quarter | 1.42 |
| Total Cash Per Share | 0.63 |
| Book Value Per Share Most Recent Quarter | -0.57 |
| Price to Book Ratio | 53.71 |
| Industry Price to Book Ratio | 5.42 |
| Sector Price to Book Ratio | 11.41 |
| Price to Sales Ratio Twelve Trailing Months | 1.42 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.75 |
| Sector Price to Sales Ratio Twelve Trailing Months | 21.39 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 66,188,000 |
| Market Capitalization | 491,114,960 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -2.42% |
| Reported EPS 12 Trailing Months | -0.48 |
| Reported EPS Past Year | -0.30 |
| Reported EPS Prior Year | -0.62 |
| Net Income Twelve Trailing Months | -31,112,000 |
| Net Income Past Year | -51,641,000 |
| Net Income Prior Year | -50,420,000 |
| Quarterly Revenue Growth YOY | 13.00% |
| 5-Year Revenue Growth | 39.36% |
| Operating Margin Twelve Trailing Months | -7.42% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 41,700,000 |
| Total Cash Past Year | 53,826,000 |
| Total Cash Prior Year | 86,952,000 |
| Net Cash Position Most Recent Quarter | -115,199,000 |
| Net Cash Position Past Year | -92,270,000 |
| Long Term Debt Past Year | 146,096,000 |
| Long Term Debt Prior Year | 121,506,000 |
| Total Debt Most Recent Quarter | 156,899,000 |
| Equity to Debt Ratio Past Year | -0.19 |
| Equity to Debt Ratio Most Recent Quarter | -0.32 |
| Total Stockholder Equity Past Year | -23,106,000 |
| Total Stockholder Equity Prior Year | 5,522,000 |
| Total Stockholder Equity Most Recent Quarter | -37,814,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -7,322,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.11 |
| Free Cash Flow Past Year | -50,717,000 |
| Free Cash Flow Prior Year | -19,471,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.17 |
| MACD Signal | -0.17 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 1.34 |
| RSI | 0.00 |
| 50-Day SMA | 6.28 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 11/11/2026 9:47:57 PM EST |